Our Team


Yaron Lemelbaum

CEO & Co-Founder

  • Private equity and venture capital professional with nearly 20 years of experience in investing, supervising, building, and growing companies from early stages to exits
  • Partnered with tier 1 venture capital firms
  • Successful track record with multiple exits

Prof. Gal Markel

Chief Medical Officer & Co-Founder

  • Director, Davidoff Comprehensive Cancer Center
  •  Founder & CSO of cCAM Biotherapeutics, acquired by Merck in 2015
  • Author of >120 research papers and inventor of over 20 patents
  • Deputy Director General, Rabin Medical Center at Clalit Health Services
  • Associate Professor, Clinical Microbiology and Immunology, Faculty of Medicine, Tel Aviv University

Michael Schickler

Senior Advisor

  •  Biotech executive with over 27 years of leading biopharmaceutical companies as well as R&D, GMP manufacturing, regulatory and clinical affairs
  • 20 year CEO of anti PD-1 development company, Curetech
  • PhD, biology, Weizmann Institute of Science

Dror Hibsh

Head of Bioinformatics

  • Awarded computational biologist with scientific achievements and publications
  • Led bioinformatics teams and gained expertise in the field of cancer and microbiome
  • Former head of bioinformatics, GeneSort
  • PhD, computational biology, Bar Ilan University

Hadas Givon

Head of Clinical Affairs

  • Clinical Project Manager with over 10 years of experience in the field of clinical trials
  • Management of clinical trials in both medical devices and medicinal products
  • Operational execution of global clinical studies across several indications from Phase I to regulatory approval

Elizabeth Tarshish

Clinical Advisor

  • Global clinical development strategy and execution executive with over 15 years of experience.
  • An expert in multi-center global clinical studies management with wide experience in new drug development and global product development through all clinical phases in varies therapeutic indications.

Scientific Advisory Board

Prof. Jennifer Wargo

Scientific Advisory Board Member

  • Author of over 175 research papers and inventor of two patents
  • Recipient of many Honors and Awards including Outstanding Investigator Award from the Society for Melanoma Research
  • Director of PRIME TR (Program for Innovative Microbiome and Translational Research)
  • Professor, Department of Genomic Medicine, MD Anderson Cancer Center
  • Professor, Department of Surgical Oncology, MD Anderson Cancer Center

Prof. Eran Segal

Scientific Advisory Board Member

  • Acclaimed Researched of Nutrition. Genetics, Microbiome and Gene Regulations and its effects
  • Works on developing quantitative models for all levels of gene regulation, including transcription, chromatin, and translation
  • Professor at the Department of Computer Science and Applied Math at The Weizmann Institute of Science
  • Ph.D. Computer Science and Genetics, Stanford University